| abstract |
<task> An object of the present invention is to provide an aqueous suspension containing a glucocorticosteroid compound as an active ingredient. Specifically, it aims to provide a pharmaceutical composition containing a glucocorticosteroid compound that can be put into practical use as an active ingredient. <Solution> The present invention relates to an aqueous suspension comprising nanoparticles of a glucocorticosteroid compound and a dispersion stabilizer, an aqueous suspension having an average particle diameter of the nanoparticles of 300 nm or less and a D90 particle diameter of 450 nm or less, and a parenteral containing the aqueous suspension To provide a pharmaceutical composition for administration, an injection, an eye drop or ear drop, more specifically, an eye drop for the treatment or prevention of an inflammatory disease of the eye, or an ear drop for the treatment or prevention of an inflammatory disease of the ear. |